Alexandre Joyeux

COO at FatiAbGen Inc.

Speaker

Dr. Joyeux holds a PhD in biochemistry and has 20 years experience in the pharmaceutical industry, leading teams across disease areas (CNS, Immunology, Oncology) and geographies. He has contributed to launch 6 products over the years, including the first curative gene therapy, and has gained in depth knowledge of the development and commercialization process. He has led the strategy to launch a multiple sclerosis drug portfolio in China, building bridges across company affiliates, physicians and patient organizations. He currently leads the Swiss office of FatiAbGen Inc., an innovative Korean biotech company developing best-in-class antibodies across modalities to treat diseases with high unmet need.